Embecta (Embecta) Days Payable : 47.72 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Days Payable?

Embecta's average Accounts Payable for the three months ended in Dec. 2023 was $48 Mil. Embecta's Cost of Goods Sold for the three months ended in Dec. 2023 was $91 Mil. Hence, Embecta's Days Payable for the three months ended in Dec. 2023 was 47.72.

The historical rank and industry rank for Embecta's Days Payable or its related term are showing as below:

EMBC' s Days Payable Range Over the Past 10 Years
Min: 46.7 Med: 50.66 Max: 56.52
Current: 46.94

During the past 5 years, Embecta's highest Days Payable was 56.52. The lowest was 46.70. And the median was 50.66.

EMBC's Days Payable is ranked worse than
69.97% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 72.855 vs EMBC: 46.94

Embecta's Days Payable increased from Dec. 2022 (41.27) to Dec. 2023 (47.72). It may suggest that Embecta delayed paying its suppliers.

Embecta Days Payable Historical Data

The historical data trend for Embecta's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Days Payable Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Days Payable

56.52

52.11

49.20

46.70

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial										41.27	46.88	51.29	49.96	47.72

Competitive Comparison of Embecta's Days Payable

For the Medical Instruments & Supplies subindustry, Embecta's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embecta's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Days Payable distribution charts can be found below:

* The bar in red indicates where Embecta's Days Payable falls into.

Embecta Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Embecta's Days Payable for the fiscal year that ended in Sep. 2023 is calculated as

	Days Payable (A: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Sep. 2022 )	+	Accounts Payable (A: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2023 )	*	Days in Period
=	( (41.4	+	53.5)	/	2 )	/	370.9	*	365
=	47.45					/	370.9	*	365
=	46.70

Embecta's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (53.5	+	42.1)	/	2 )	/	91.4	*	365 / 4
=	47.8					/	91.4	*	365 / 4
=	47.72

Embecta Days Payable Related Terms

Thank you for viewing the detailed overview of Embecta's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (Embecta) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (NAS:EMBC) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Executives

David F Melcher	director	1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Devdatt Kurdikar	officer: President and CEO	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jacob Elguicze	officer: Chief Financial Officer	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey Z Mann	officer: SVP, GC, Head Corp. Dev., Secy	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Jean Casner	officer: Chief Human Resources Officer	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Ajay Kumar	officer: SVP and CHRO	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Shaun Curtis	officer: SVP, Global Manuf./Sup. Chain	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Albritton	director	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880
Milton Mayo Morris	director	2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Brian Capone	officer: VP, CAO & Corp. Controller	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Carrie L Anderson	director	3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515
Claire Pomeroy	director	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Robert J. Hombach	director	C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015